| Benson HA. 2000. Assessment and clinical implications of absorption of sunscreens across skin. Am J Clin Dermatol 1(4): 217-224. |
| Bryden AM, Moseley H, Ibbotson SH, Chowdhury MM, Beck MH, Bourke J, et al. 2006. Photopatch testing of 1155 patients: results of the U.K. multicentre photopatch study group. Br J Dermatol 155(4): 737-747. |
| CIR (Cosmetic Ingredient Review). 2006. CIR Compendium, containing abstracts, discussions, and conclusions of CIR cosmetic ingredient safety assessments. Washington DC. |
| CIR (Cosmetic Ingredient Review). 2006. CIR Compendium, containing abstracts, discussions, and conclusions of CIR cosmetic ingredient safety assessments. Washington DC. |
| Danovaro R, Bongiorni L, Corinaldesi C, Giovannelli D, Damiani E, Astolfi P, Greci L, Pusceddu A. "Sunscreens cause coral bleaching by promoting viral infections." Environ Health Perspect. 2008 Apr;116(4):441-7. |
| EC (Environment Canada). 2008. Domestic Substances List Categorization. Canadian Environmental Protection Act (CEPA) Environmental Registry. |
| EU (European Union)- Strategy for Endocrine Disrupters 2007. Commision on endocrin disruption requested by the European Parliament in 1998. |
| European Commission. 2013. Cosing, the European Commission database with information on cosmetic substances and ingredients. Accessed on March 1, 2013 at http://ec.europa.eu/consumers/cosmetics/cosing/ . |
| Hanson KM, Gratton E, Bardeen CJ. 2006. Sunscreen enhancement of UV-induced reactive oxygen species in the skin. Free Radic Biol Med 41(8): 1205-1212. |
| Hazelton Labs, 1953; Lewerenz, 1972 |
| IFRA (International Fragrance Assocication). 2010. IFRA Fragrance Ingredient List based on 2008 Use Survey. Accessed online 01/04/2010: http://www.ifraorg.org/Home/News/Latest-News/page.aspx/66?xf_itemId=43&xf_selectionDatapartId=25 |
| Japan Ministry of Health, Labour and Welfare. 2006. Standards for Cosmetics. Evaluation and Licensing Division. Pharmaceutical and Food Safety Bureau. |
| Kunz PY, Galicia HF, Fent K. 2006. Comparison of in vitro and in vivo estrogenic activity of UV filters in fish. Toxicol Sci 90(2): 349-361. |
| NLM (National Library of Medicine). 2012. PubMed online scientific bibliography data. http://www.pubmed.gov. |
| Pont AR, Charron AR, Brand RM. 2004. Active ingredients in sunscreens act as topical penetration enhancers for the herbicide 2,4-dichlorophenoxyacetic acid. Toxicol Appl Pharmacol 195(3): 348-354. |
| Rodriguez E, Valbuena MC, Rey M, Porras de Quintana L. 2006. Causal agents of photoallergic contact dermatitis diagnosed in the national institute of dermatology of Colombia. Photodermatol Photoimmunol Photomed 22(4): 189-192. |
| SCCP (2006). "Opinion on Benzophenone-3." European Commission - The Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers. SCCP/1069/06 Retrieved from http://ec.europa.eu/health/ph_risk/committees/04_sccp/sccp_opinions_en.htm. |
| Schlumpf M, Kypke K, Vökt C, Birchler M, Durrer S, Faass O, et al. 2008. Endocrine Active UV Filters: Developmental Toxicity and Exposure Through Breast Milk. Chimia 62: 1-7. |
| Schlumpf M, Schmid P, Durrer S, Conscience M, Maerkel K, Henseler M, et al. 2004. Endocrine activity and developmental toxicity of cosmetic UV filters--an update. Toxicology 205(1-2): 113-122. |
| Veysey EC, Orton DI. 2006. Photoallergic contact cheilitis due to oxybenzone found in a lip cosmetic. Contact Dermatitis 55(1): 54. |
| Wolff MS, Teitelbaum SL, Windham G, Pinney SM, Britton JA, Chelimo C, et al. 2007. Pilot study of urinary biomarkers of phytoestrogens, phthalates, and phenols in girls. Environ Health Perspect 115(1): 116-121. |
| Ziolkowska A, Belloni AS, Nussdorfer GG, Nowak M, Malendowicz LK. 2006. Endocrine disruptors and rat adrenocortical function: studies on freshly dispersed and cultured cells. Int J Mol Med 18(6): 1165-1168. |
| {Allen, 1996} |
| {CTFA, 1979; FDA,1978; Leberco Labs, 1979; FDRL, 1978} |
| {CTFA, 1980; DHEW, 1978; Hill Top Research Labs, 1979; Litton Bioneics, 1979} |
| {FDRL, 1978; Leberco Labs, 1979; Testkit Labs, 1980; FDA, 1978; CTFA,1979} |
| {Gupta, 1999; Potard, 2000} |
| {Hayden, 1997; Hayden, 2005} |
| {Homrowski, 1968; Lewerenz, 1972; IBL, 1964; Hazelton Labs, 1953} |
| {IBL, 1965; AAC, 1976} |
| {IBL, 1967; Kligman, 1976; FDA, 1978; CFTA, 1980; FDRL, 1978} |
| {IBL,1967; IBL, 1967; IBL, 1965; ACC, 1976; Hazelton Labs, 1953} |
| {Journe, 1999} |
| {Ma, 2003} |
| {NTP, 1990} |